US crude oil production
The EIA (U.S. Energy Information Administration) estimates that US crude oil production rose by 46,000 bpd (barrels per day) to 9,553,000 bpd on October 20–27, 2017. Production rose 0.5% week-over-week and by 1,031,000 bpd or 12.1% year-over-year.
US crude oil production is near a 28-month high. So far, high US oil production has been weighing on crude oil (USL) (UCO) prices in 2017. US oil (UWT) prices have fallen 4.1% year-to-date. However, crude oil prices have risen ~30% since the lows in June 2017. Oil and gas producers (VDE) (IEZ) like EOG Resources (EOG), Whiting Petroleum (WLL), and Sanchez Energy (SN) benefit from higher oil prices.
Non-OPEC crude oil production
The US, Canada, Russia, Brazil, and China are the significant non-OPEC (Organization of the Petroleum Exporting Countries) crude oil producers. The EIA estimates that non-OPEC oil production averaged 58.48 MMbpd (million barrels per day) and 57.99 MMbpd in 2015 and 2016, respectively. It’s expected to average 58.63 MMbpd and 60.12 MMbpd in 2017 and 2018, respectively. The US, Canada, Brazil, and Kazakhstan would be the major contributors to a rise in non-OPEC production in 2018.
Goldman Sachs estimates for US crude oil production
According to Goldman Sachs, US crude oil production could average between 9.6 MMbpd and 9.7 MMbpd by the end of 2017. It would be the highest production in the last 30 years.
The EIA estimates that US production averaged 9.4 MMbpd in 2015 and 8.86 MMbpd in 2016. It’s expected to average 9.24 MMbpd in 2017 and 9.92 MMbpd in 2018.
The rise in non-OPEC and record US crude oil could cap the upside for crude oil (SCO) (BNO) prices. It could also offset some of the impacts of the ongoing production cuts. Meanwhile, production cuts are shrinking the global crude oil glut.
Next, we’ll analyze how US gasoline inventories impact oil prices.
US distillate inventories fell by 302,000 barrels to 128.9 MMbbls (million barrels) on October 20–27, 2017. It's the lowest level since April 10, 2015.
Hibbett Sports (HIBB) stock surged 22.3% as of 1:54 PM ET today as the company reported impressive results for fiscal 2019's fourth quarter, which ended on February 2.
Wall Street analysts expect a potential upside of 21.63% for Alexion Pharmaceuticals based on the stock's closing price on March 21.
Today, we got another round of dismal data points from Europe (VGK)(EZU). According to a Markit survey, Germany’s (EWG) March PMI Composite Output Index fell to a 69-month low of 51.5.
On March 21, US crude oil’s implied volatility was 24.9%, which was 6.7% below its 15-day average. Usually, lower implied volatility supports oil prices.
The overall cannabis sector took a hit today amid the broader market's declines. The volatility index (VIX) jumped 17.9%, and the cannabis sector is more sensitive than the market.
The tech-heavy NASDAQ Composite Index (QQQ) is on track to post its 12th weekly gain in 13 weeks.